SCHEMBL3158262

SCHEMBL3158262

CC(C)C(C)C.NC(=O)C(N)Cc1c[nH]c2ccccc12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.70
MAPT P10636 2/20 0.70
MEN1 O00255 1/20 0.70
LMNA P02545 1/20 0.70
MPO P05164 1/20 0.70
TSHR P16473 1/20 0.70
BLM P54132 1/20 0.70
PMP22 Q01453 1/20 0.70
KMT2A Q03164 1/20 0.70
HIF1A Q16665 1/20 0.70
HTR2A P28223 2/20 0.64
ADRB1 P08588 1/20 0.64
HTR1A P08908 1/20 0.64
ADRA2A P08913 1/20 0.64
SLC6A2 P23975 1/20 0.64
HTR1D P28221 1/20 0.64
HTR1B P28222 1/20 0.64
HTR2C P28335 1/20 0.64
HTR1E P28566 1/20 0.64
SLC6A4 P31645 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8403649 0.94 KDM4E (0.78) KDM4EMAPTMEN1LMNAMPO
SCHEMBL29400974 0.94 KDM4E (0.78) KDM4EMAPTMEN1LMNAMPO
SCHEMBL29865910 0.94 KDM4E (0.78) KDM4EMAPTMEN1LMNAMPO
SCHEMBL358778 0.94 KDM4E (0.78) KDM4EMAPTMEN1LMNAMPO
SCHEMBL29382126 0.94 KDM4E (0.78) KDM4EMAPTMEN1LMNAMPO
SCHEMBL8403647 0.94 KDM4E (0.78) KDM4EMAPTMEN1LMNAMPO
SCHEMBL2726806 0.94 KDM4E (0.78) KDM4EMAPTMEN1LMNAMPO
SCHEMBL617181 0.94 KDM4E (0.78) KDM4EMAPTMEN1LMNAMPO
Hydrochloric Acid SCHEMBL3784313 0.93 KDM4E (0.76) KDM4EMAPTMEN1LMNAMPO
Hydrochloric Acid SCHEMBL901447 0.93 KDM4E (0.76) KDM4EMAPTMEN1LMNAMPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1386908-B1 AMINE DERIVATIVE WITH POTASSIUM CHANNEL REGULATORY FUNCTION, ITS PREPARATION AND USE INST PHARM & TOXICOLOGY AMMS (CN) 2010-03-03 EP claimed
US-7560473-B2 Amine derivative with potassium channel regulatory function, its preparation and use INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES, P.L.A. (CN) 2009-07-14 US claimed
CN-1205175-C Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science INST OF TOXICANT AND MEDICAMEN (CN) 2005-06-08 CN claimed
US-20040266822-A1 Amine derivative with potassium channel regulatory function, its preparation and use INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. (CN) 2004-12-30 US claimed
EP-1386908-A1 AMINE DERIVATIVE WITH POTASSIUM CHANNEL REGULATORY FUNCTION, ITS PREPARATION AND USE Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. (CN) 2004-02-04 EP claimed
CN-1415596-A Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science INST OF TOXICANT AND MEDICAMEN (CN) 2003-05-07 CN claimed
CN-1365966-A Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application INST OF TOXIC MEDICAL MATERIAL (CN) 2002-08-28 CN claimed
CN-1365967-A Amine derivative with K channel regulation function and its preparing process and application INST OF TOXIC MEDICAL MATERIAL (CN) 2002-08-28 CN claimed
CN-1250518-C Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application INST OF TOXIC MEDICAL MATERIAL (CN) 2006-04-12 CN disclosed
CN-1205175-C Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science INST OF TOXICANT AND MEDICAMEN (CN) 2005-06-08 CN disclosed
CN-1415596-A Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science INST OF TOXICANT AND MEDICAMEN (CN) 2003-05-07 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040266822-A1 Amine derivative with potassium channel regulatory function, its preparation and use KCNMA1, KCNA5, KCNA1 KDM4E 551/4885MAPT 2941/4885MEN1 2054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.